According to Barinthus Biotherapeutics's latest financial reports the company's current EPS (TTM) is -1,19ย โฌ. In 2022 the company made an earnings per share (EPS) of 0,13ย โฌ an increase over its 2021 EPS that were of -1,87ย โฌ.